Premium
AN OPEN‐LABEL STUDY OF SAFETY AND TOLERABILITY OF AEROFACT TM (AEROSOLIZED ALVEOFACT®) IN PRETERM INFANTS ON NCPAP AT RISK FOR WORSENING RESPIRATORY DISTRESS SYNDROME
Publication year - 2019
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1111/jpc.14409_66
Subject(s) - medicine , tolerability , respiratory distress , aerosolization , continuous positive airway pressure , intensive care medicine , anesthesia , pediatrics , adverse effect , inhalation , obstructive sleep apnea
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom